Company intelligence / Profile preview

Jodas Expoim

Hyderabad, Telangana, Indiajodasexpoim.in ↗

Ownership: Private
Employees: ~443
Development stage: Commercial

Overview

Jodas Expoim is an active Indian specialty pharmaceutical company focused on developing, manufacturing, and commercializing high-quality generic injectable and oral medicines across anti-infective, oncology, contrast media, and critical care segments. The company has over forty approved products commercialized in more than fifty countries with a strong presence in Russia/CIS regions. Its business model centers around affordable branded generics with state-of-the-art manufacturing facilities certified for global supply. No novel clinical results are reported as the portfolio consists primarily of generics.

Therapeutic areas: OtherOncologyInfectious Diseases
Modalities: Small molecules (injectables and orals)Contrast media (injectables)Generics
Industry: Biotech

Beyond the preview

Go deeper on Jodas Expoim.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jodas Expoim.

Explore the full profile